Is there an association between 5-azacitidine and ototoxicity?
Afshan
A
Malik
Seema
S
Misbah
Colette
C
Spaccavento
Ian
I
Yudelman
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use*; D001374:Azacitidine / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine